There’s 20–40% more ARR inside your portfolio that isn’t being captured.
You know some companies in your portfolio are underperforming, but it's unclear why. We help seed-stage and Series A investors identify which companies are underperforming due to poor monetization and pricing architecture, and help them unlock the hidden ARR potential, by diagnosing the Value Gap at the company level.
What is the Value Gap?
The Value Gap is the difference between the value a company creates and the value it actually captures through pricing, packaging, and sales. At the seed stage, most companies don’t fully understand this yet.
The Bad News
The Value Gap doesn’t show up clearly.
It often looks like:
- Weak conversion
- Slower-than-expected growth
- Pricing pressure
- Inconsistent sales performance
So it gets misdiagnosed as:
- A sales problem
- A marketing problem
- Or a product problem
Which leads to:
- Misallocated time and capital
- Unnecessary burn
- Missed growth targets
- Lower returns and multiples
What This Means for Your Portfolio
Across a typical portfolio:
- A subset of your companies are underperforming due to poor pricing and packaging
- Another subset has hidden ARR potential that isn’t being captured
- And it’s difficult to tell which is which early enough to act
What’s Possible When the Value Gap Is Identified Early
When monetization issues are surfaced early at the company level, we typically see:
- Higher ACV potential unlocked
- Improved conversion from existing pipelines
- Stronger revenue quality
- More efficient use of capital
All without requiring:
- Additional headcount
- Increased marketing spend
What Causes the Value Gap (Across Portfolio Companies)
→ Founders can’t quantify the true value of their offers for buyers
Result: Underpricing and capped ACV
→ Offers are built around product features, not buyer outcomes
Result: Lost deals and lower conversion
→ Value is not clearly communicated in sales conversations
Result: Discounting, slower sales cycles, lower-quality ARR
Why This Is Hard to See
Each company looks different on the surface and in fast-moving categories (especially AI), external benchmarks are unreliable. So the real question becomes:
→ Is this company capturing the value it’s already creating?
_______________________________________________________________________
How We Help (Portfolio Monetization Diagnostic)
We can run a Revenue Leak Diagnostic across your portfolio to:
- Diagnose which companies have pricing-related growth constraints
- Flag where ARR is being capped and where more ARR potential exists
- Provide clear, prioritized signals on where founders need to focus
Each company is evaluated independently based on how well it captures its own value.
Most investors assume:
That if a company isn’t growing, it’s a sales, marketing, or product issue.
But, in many cases, it’s actually a value-capture issue.
We help you see that early to be able to fix it.
Outcome
You get a clear answer to:
Which companies need attention and why, before it shows up in missed growth targets.
Why work with us
Investors shoulder significant risk, invest their own time, and support founders along the entire journey. Our goal is to help the entire team reduce their risk and unlock more ROI along the way.
A recent client, Tapajyoti (Tukan) Das from Gia, a seed stage B2B SaaS/AI startup said, "ACV is up by 80% and we’ve tripled revenue within 3 months because Carolyn gave us clarity and confidence around how to fix our pricing tiers and how to talk about what we offer in a way customers care about. She is one of the best coaches we’ve ever worked with.”
The goal for every startup/portfolio we work with is:
- 20–80% higher ACV
- 2–4x ARR growth from the same sales pipeline
- Higher quality revenue
- More efficient burn
